Jasper Therapeutics enters $100M ATM equity offering with Jefferies; terminates prior Cantor agreement

Jasper Therapeutics, Inc.

Company entered Open Market Sale Agreement with Jefferies LLC to sell up to $100M of common stock.
Jefferies will receive 3.0% commission on gross sales price per share; issuer has no obligation to sell.
Prior ATM agreement with Cantor Fitzgerald terminated effective March 14, 2025; no shares sold under it.
Offering will be made under new S-3 registration statement filed March 19, 2025.
No material penalties incurred from termination of Cantor agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.